♪ PODCAST: A novel enzyme biomarker for prostate cancer with Ralf Hoffmann @ Philips
By NextLevel Life Sciences - September 14, 2018

This is an extended discussion covering PDE4D7 a novel tissue biomarker which supports the treatment stratification of prostate cancer patients and is currently being translated into the clinic as a diagnostic.
Our guest: Ralf Hoffmann, Principal Scientist - Medical Biomarker Research Oncology from Philips, Netherlands.